1. Home
  2. LSH vs GNPX Comparison

LSH vs GNPX Comparison

Compare LSH & GNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSH
  • GNPX
  • Stock Information
  • Founded
  • LSH 2018
  • GNPX 2009
  • Country
  • LSH United States
  • GNPX United States
  • Employees
  • LSH N/A
  • GNPX N/A
  • Industry
  • LSH
  • GNPX Biotechnology: Pharmaceutical Preparations
  • Sector
  • LSH
  • GNPX Health Care
  • Exchange
  • LSH NYSE
  • GNPX Nasdaq
  • Market Cap
  • LSH 6.6M
  • GNPX 6.6M
  • IPO Year
  • LSH 2024
  • GNPX 2018
  • Fundamental
  • Price
  • LSH $0.92
  • GNPX $0.28
  • Analyst Decision
  • LSH
  • GNPX
  • Analyst Count
  • LSH 0
  • GNPX 0
  • Target Price
  • LSH N/A
  • GNPX N/A
  • AVG Volume (30 Days)
  • LSH 14.2K
  • GNPX 3.4M
  • Earning Date
  • LSH 08-01-2025
  • GNPX 08-08-2025
  • Dividend Yield
  • LSH N/A
  • GNPX N/A
  • EPS Growth
  • LSH N/A
  • GNPX N/A
  • EPS
  • LSH N/A
  • GNPX N/A
  • Revenue
  • LSH $16,270,095.00
  • GNPX N/A
  • Revenue This Year
  • LSH N/A
  • GNPX N/A
  • Revenue Next Year
  • LSH N/A
  • GNPX N/A
  • P/E Ratio
  • LSH N/A
  • GNPX N/A
  • Revenue Growth
  • LSH N/A
  • GNPX N/A
  • 52 Week Low
  • LSH $0.82
  • GNPX $0.20
  • 52 Week High
  • LSH $4.34
  • GNPX $3.97
  • Technical
  • Relative Strength Index (RSI)
  • LSH N/A
  • GNPX 55.29
  • Support Level
  • LSH N/A
  • GNPX $0.25
  • Resistance Level
  • LSH N/A
  • GNPX $0.27
  • Average True Range (ATR)
  • LSH 0.00
  • GNPX 0.03
  • MACD
  • LSH 0.00
  • GNPX 0.00
  • Stochastic Oscillator
  • LSH 0.00
  • GNPX 90.71

About LSH LAKESIDE HOLDING LTD

Lakeside Holding Ltd i an integrated cross-border supply chain solution provider with a strategic focus on the Asian market including China and South Korea. It provides customized cross-border ocean freight solutions and airfreight solutions in the U.S, including cross-border freight consolidation and forwarding services; customs clearance services; warehousing and distribution services and U.S. domestic ground transportation services.

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

Share on Social Networks: